| 1. | | Completed | Effect of AC2993 Compared with Insulin Glargine in Patients with Type 2 Diabetes Also Using Combination Therapy with Sulfonylurea and Metformin
Condition: Diabetes Mellitus, Type 2 |
| 2. | | Completed | Effect of Exenatide Monotherapy on Glucose Control in Subjects With Type 2 Diabetes Mellitus
Condition: Diabetes Mellitus, Type 2 |
| 3. | | No longer recruiting | Evaluation of an Orally Administered Medication When Taken in Conjunction with Pramlintide
Condition: Diabetes Mellitus, Non-Insulin-Dependent |
| 4. | | No longer recruiting | Evaluation of Dose-titration of Pramlintide During Initiation of Therapy in Patients Trying to Improve Glucose Control
Condition: Diabetes Mellitus, Type 1 |
| 5. | | No longer recruiting | Evaluation of the Bioavailability of Pramlintide
Conditions: Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2 |
| 6. | | No longer recruiting | Evaluation of the Effect of Pramlintide on Satiety and Food Intake
Conditions: Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2 |
| 7. | | No longer recruiting | Evaluation of the Effect on Glucose Control and Safety of AC2993 in Patients With Type 2 Diabetes Treated With Metformin, Sulfonylurea, or Metformin and Sulfonylurea Combination
Condition: Diabetes Mellitus, Non-Insulin-Dependent |
| 8. | | No longer recruiting | Evaluation of the Effect on Glucose Control and the Safety and Tolerability of AC2993 in Patients With Type 2 Diabetes Mellitus
Condition: Diabetes Mellitus, Non-Insulin-Dependent |
| 9. | | Completed | Evaluation of the Effect on Glucose Control of AC2993 in Patients With Type 2 Diabetes Mellitus
Condition: Diabetes Mellitus, Type 2 |
| 10. | | Completed | Evaluation of the Effect on Glucose Control of AC2993 in Patients With Type 2 Diabetes Mellitus Treated With a Sulfonylurea
Condition: Diabetes Mellitus, Non-Insulin-Dependent |
| 11. | | Completed | Evaluation of the Effect on Glucose Control of AC2993 in Patients With Type 2 Diabetes Mellitus Treated With Metformin
Condition: Diabetes Mellitus, Type 2 |
| 12. | | No longer recruiting | Exenatide Compared with Twice-Daily Biphasic Insulin Aspart in Patients with Type 2 Diabetes Using Sulfonylurea and Metformin
Condition: Diabetes Mellitus, Type 2 |
